文献速递白内障与屈光手术

比较飞秒激光LASIK与微切口透镜取出术的随机临床试验

Randomized Clinical Trial Comparing Femtosecond LASIK and Small-Incision Lenticule Extraction.
PubMed 文献 · Ophthalmology · 2019-09-12

这项前瞻性随机配对眼单盲临床试验在单一三级转诊眼科中心纳入70例近视及近视散光患者,一眼行SMILE、另一眼行LASIK。3个月时SMILE眼99%、LASIK眼97%的等效球镜在目标矫正±1.0 D以内(P=1.0);12个月时两组在有效性、可预测性和安全性方面相似,结果提示SMILE可产生有前景的屈光结果。

要点

  • 3个月时SMILE眼99%与LASIK眼97%的等效球镜在目标矫正±1.0 D以内(P=1.0)。
  • 3个月时有效性指数SMILE 0.97±0.20 vs LASIK 0.99±0.20(P=0.56)。
  • 12个月时UDVA≥20/20比例SMILE 85% vs LASIK 83%(P=0.81)。

核心结论

  • 这项随机试验结果提示,SMILE在3个月和12个月随访中在可预测性、有效性和安全性方面产生有前景的屈光结果。

研究设计与样本

  • 前瞻性、随机、配对眼、单盲临床试验。
  • 连续纳入的合格患者在单一三级转诊眼科中心随机接受一眼SMILE、另一眼LASIK。
  • 共招募70例连续患者(平均年龄28±5岁;64%为女性;全部为亚洲人)。
  • 两眼均使用VisuMax 500-kHz飞秒激光系统,LASIK眼随后使用WaveLight EX500准分子激光进行消融。
  • 主要结局指标为3个月时的屈光可预测性,次要结局为3个月和12个月时的有效性和安全性。

主要发现

  • 术前等效球镜两眼间无差异(-5.3±1.8 D vs -5.2±1.7 D;P=0.87)。
  • 3个月时SMILE眼99%和LASIK眼97%达到目标矫正等效球镜±1.0 D以内(P=1.0)。
  • 3个月时有效性指数SMILE 0.97±0.20 vs LASIK 0.99±0.20(P=0.56)。
  • 3个月时UDVA 20/40或更好SMILE 100% vs LASIK 100%(P=1.0),UDVA 20/20或更好SMILE 84% vs LASIK 87%(P=0.63)。
  • 3个月时安全性指数SMILE 1.1±0.2 vs LASIK 1.1±0.2(P=0.57);12个月时有效性SMILE 85% vs LASIK 83% UDVA≥20/20(P=0.81),可预测性SMILE 99% vs LASIK 99%在目标矫正等效球镜±1.0 D以内(P=1.0),安全性SMILE 1.15±0.20 vs LASIK 1.15±0.20(P=0.93)。

关键数值与推荐

  • 3个月时可预测性:SMILE眼99% vs LASIK眼97%达到目标矫正等效球镜±1.0 D以内(P=1.0)。
  • 3个月时有效性指数:SMILE 0.97±0.20 vs LASIK 0.99±0.20(P=0.56)。
  • 3个月时UDVA 20/20或更好:SMILE 84% vs LASIK 87%(P=0.63)。
  • 12个月时UDVA≥20/20:SMILE 85% vs LASIK 83%(P=0.81)。
  • 12个月时安全性指数:SMILE 1.15±0.20 vs LASIK 1.15±0.20(P=0.93)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare femtosecond LASIK with small-incision lenticule extraction (SMILE) for the treatment of myopia and myopic astigmatism. DESIGN: Prospective, randomized, paired-eye, single-masked clinical trial. PARTICIPANTS: Consecutive eligible patients were randomized to undergo SMILE and LASIK in either eye at a single tertiary referral eye center. METHODS: Patients were treated in each eye using the VisuMax (Carl Zeiss Meditec, Jena, Germany) 500-kHz femtosecond laser system. Excimer ablation was subsequently performed using the WaveLight EX500 excimer laser (Alcon Laboratories, Inc, Fort Worth, TX) in the eye for LASIK. MAIN OUTCOME MEASURE: Refractive predictability at 3 months. Secondary outcomes were refractive outcomes, that is, efficacy and safety at 3 and 12 months. RESULTS: We recruited 70 consecutive patients (mean age, 28±5 years; 64% women; all Asian) with no difference in preoperative spherical equivalent (SE) between eyes (-5.3±1.8 diopters [D] vs. -5.2±1.7 D; P = 0.87). At 3 months, 99% of SMILE eyes and 97% of LASIK eyes achieved SE within ±1.0 D of attempted correction (P = 1.0). Small-incision lenticule extraction achieved similar results as LASIK in terms of efficacy index (0.97±0.20 vs. 0.99±0.20; P = 0.56), uncorrected distance visual acuity (UDVA) of 20/40 or better (100% vs. 100%; P = 1.0), and UDVA of 20/20 or better (84% vs. 87%; P = 0.63). Safety index (1.1±0.2 vs. 1.1±0.2; P = 0.57) was similar between SMILE and LASIK eyes at 3 months. At 12 months, SMILE was similar to LASIK in terms of efficacy (85% vs. 83% UDVA ≥20/20; P = 0.81), predictability (99% vs. 99% ±1.0 D of attempted correction SE; P = 1.0), and safety (1.15±0.20 vs. 1.15±0.20; P = 0.93). CONCLUSIONS: The results from this randomized trial suggest that SMILE produced promising refractive outcomes in terms of predictability, efficacy, and safety at 3 and 12 months of follow-up.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Ang M, Farook M, Htoon HM, et al. Randomized Clinical Trial Comparing Femtosecond LASIK and Small-Incision Lenticule Extraction. Ophthalmology. 2019. PMID: 31619358. doi:10.1016/j.ophtha.2019.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。